Zentalis Pharmaceuticals, Inc.
$336.07M- Market cap
- $287.40M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.98x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.26x
$4.01Latest market snapshot
Implied fair value · at MLI's multiple
$3.1720.8% below market
0.94 ZNTL revenue / share×3.37x MLI P/S=$3.17
Market $4.01Implied $3.17
MLI · current priceP/S 3.37x
$63.76Latest market snapshot
Implied fair value · at ZNTL's multiple
$80.5326.3% above market
18.89 MLI revenue / share×4.26x ZNTL P/S=$80.53
Market $63.76Implied $80.53